Cherry Creek Investment Advisors Inc. Sells 8,067 Shares of GE HealthCare Technologies Inc. $GEHC

Cherry Creek Investment Advisors Inc. decreased its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 31.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 17,358 shares of the company’s stock after selling 8,067 shares during the period. Cherry Creek Investment Advisors Inc.’s holdings in GE HealthCare Technologies were worth $1,424,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of the company. E Fund Management Hong Kong Co. Ltd. lifted its position in GE HealthCare Technologies by 130.7% during the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock valued at $26,000 after purchasing an additional 196 shares during the last quarter. Godsey & Gibb Inc. purchased a new stake in shares of GE HealthCare Technologies during the 3rd quarter valued at $26,000. Oakworth Capital Inc. raised its position in shares of GE HealthCare Technologies by 1,876.2% during the 3rd quarter. Oakworth Capital Inc. now owns 415 shares of the company’s stock valued at $31,000 after buying an additional 394 shares in the last quarter. Piscataqua Savings Bank lifted its holdings in shares of GE HealthCare Technologies by 173.4% during the 3rd quarter. Piscataqua Savings Bank now owns 473 shares of the company’s stock worth $36,000 after acquiring an additional 300 shares during the last quarter. Finally, Salomon & Ludwin LLC grew its position in GE HealthCare Technologies by 326.5% in the third quarter. Salomon & Ludwin LLC now owns 482 shares of the company’s stock worth $37,000 after acquiring an additional 369 shares in the last quarter. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Price Performance

GEHC opened at $71.18 on Wednesday. The company has a current ratio of 1.37, a quick ratio of 1.13 and a debt-to-equity ratio of 0.91. The company has a market cap of $32.48 billion, a price-to-earnings ratio of 15.61, a price-to-earnings-growth ratio of 1.51 and a beta of 1.03. The stock has a fifty day simple moving average of $77.49 and a two-hundred day simple moving average of $78.18. GE HealthCare Technologies Inc. has a 12-month low of $57.65 and a 12-month high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.04. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The company had revenue of $5.70 billion during the quarter, compared to analyst estimates of $5.60 billion. During the same period last year, the business earned $1.45 EPS. GE HealthCare Technologies’s quarterly revenue was up 7.1% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Research analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be given a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Thursday, April 2nd. GE HealthCare Technologies’s dividend payout ratio is 3.07%.

Wall Street Analyst Weigh In

GEHC has been the subject of a number of recent research reports. Evercore boosted their target price on GE HealthCare Technologies from $95.00 to $98.00 and gave the company an “outperform” rating in a research note on Thursday, February 5th. BTIG Research restated a “buy” rating and set a $91.00 price target on shares of GE HealthCare Technologies in a research report on Thursday, March 19th. Jefferies Financial Group lifted their price target on GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a research note on Thursday, December 11th. Wells Fargo & Company raised their target price on shares of GE HealthCare Technologies from $95.00 to $97.00 and gave the stock an “overweight” rating in a report on Thursday, February 5th. Finally, UBS Group downgraded shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and lifted their target price for the stock from $73.00 to $77.00 in a research note on Thursday, January 15th. Seven equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $92.17.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.